John P Sharp Insider Trading
Get free email notifications about insider trading for John P Sharp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John P Sharp. John P Sharp is a Treasurer in SEQUENOM INC ($SQNM) and a CFO and Secretary in PhaseBio Pharmaceuticals Inc ($PHAS) and a Chief Financial Officer in PhaseBio Pharmaceuticals Inc ($PHAS).
Address: 3595 JOHN HOPKINS COURT SAN DIEGO 92121 CA
Companies in which John P Sharp is an Insider
PhaseBio Pharmaceuticals Inc
Trading Symbol: PHASIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John P Sharp: Chief Financial Officer, CFO and Secretary
Holdings: 41,305 shares
Latest Transaction: Feb 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SEQUENOM INC
Trading Symbol: SQNMIndustry: MEASURING & CONTROLLING DEVICES, NEC [3829]
Position of John P Sharp: Treasurer
Holdings: 3,219 shares
Latest Transaction: Jan 22 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of John P Sharp
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 09 2021 | PHAS | PhaseBio Pharmaceu ... | Sharp John P | Chief Financial Off ... | Option Exercise | A | 4.31 | 76,500 | 329,715 | 76,500 | |
Feb 09 2021 | PHAS | PhaseBio Pharmaceu ... | Sharp John P | Chief Financial Off ... | Option Exercise | A | 4.31 | 76,500 | 329,715 | 76,500 | |
Nov 23 2020 | PHAS | PhaseBio Pharmaceu ... | Sharp John P | Chief Financial Off ... | Grant | A | 3.00 | 1,305 | 3,915 | 41,305 | 40 K to 41.3 K (+3.26 %) |
Aug 17 2020 | PHAS | PhaseBio Pharmaceu ... | Sharp John P | Chief Financial Off ... | Option Exercise | M | 1.69 | 5,000 | 8,450 | 105,582 | |
Aug 17 2020 | PHAS | PhaseBio Pharmaceu ... | Sharp John P | Chief Financial Off ... | Buy | M | 1.69 | 5,000 | 8,450 | 40,000 | 35 K to 40 K (+14.29 %) |
Feb 14 2020 | PHAS | PhaseBio Pharmaceu ... | Sharp John P | Chief Financial Off ... | Option Exercise | A | 5.19 | 100,000 | 519,000 | 100,000 | |
Aug 22 2019 | PHAS | PhaseBio Pharmaceu ... | Sharp John P | CFO and Secretary | Option Exercise | M | 1.44 | 5,000 | 7,200 | 4,038 |